Items 5251 ~ 5260 of 5389, Page 526 of 539 
  01/17/2005 Proceedings of the National Academy of Sciences, EurekaAlert!-AAAS - Health and Science
Research sheds light on how cancer cells become resistant to treatment - A new study by researchers at Memorial Sloan-Kettering Cancer Center and The Johns Hopkins University provides new insight into how tumor cells can become resistant to anti-cancer therapy.
  01/17/2005 Lancet, EurekaAlert!-AAAS - Health and Science
New genetic mutation linked to Parkinson's disease - Tatiana Foroud, Ph.D., of the Indiana University School of Medicine, principal investigator of the multi-site Parkinson Study Group study says that a mutation in a recently discovered Parkinson's disease gene (LRRK2) is the most common genetic cause of inherited forms of the disease. The study appears in January issue of the Lancet.
  01/17/2005 NIH/National Institute on Aging, EurekaAlert!-AAAS - Health and Science
Scientists detect probable genetic cause of some Parkinson's disease cases - Two new studies strongly suggest that a mutation in a recently discovered gene is the most common genetic cause of Parkinson's disease identified to date. The discovery by an international research team provides fresh evidence that genetics may contribute to the development of some cases of Parkinson's disease. The findings could lead to the development of a genetic test to detect the mutation in individuals at risk.
  01/17/2005 Lancet, EurekaAlert!-AAAS - Health and Science
Study identifies the most common genetic cause of Parkinson's disease - Researchers have found that a single mutation in a recently discovered Parkinson's disease gene is responsible for 5 percent of inherited Parkinson's disease cases. The finding opens the door to the possibility of genetic screening for the LRRK2 gene mutation, which is believed to be the most common genetic cause of inherited Parkinson's disease identified to date.
  01/17/2005 Annals of Internal Medicine, EurekaAlert!-AAAS - Clinical
Tip sheet Annals of Internal Medicine, Jan. 18, 2005 - This issue includes the following two articles: A single office-based stool blood test (FOBT) is a poor, but often used, screening test for colorectal cancer; Improving HDL cholesterol limited progression of heart disease.
  01/17/2005 Cancer Cell, EurekaAlert!-AAAS - Clinical
Combination therapy boosts effectiveness of telomere-directed cancer cell death - A new research study published in the January issue of Cancer Cell provides exciting new information about how to boost the effectiveness of a promising cancer treatment that targets telomeres in an attempt to interfere with the ability of a cancer cell to continuously divide.
  01/17/2005 Cancer Cell, EurekaAlert!-AAAS - Clinical
Blood test shows promise as monitor for antiangiogenic cancer therapy - Scientists have uncovered critical information that may lead to an urgently needed method for effective monitoring of antiangiogenic cancer therapies. The research, published in the January issue of Cancer Cell, is likely to facilitate development of new antiangiogenic drugs or treatment strategies and allow for accurate determination of the optimal drug doses to use for such therapies.
  01/17/2005 Journal of Experimental Medicine, EurekaAlert!-AAAS - Health and Science
Jump-starting T cells in skin cancer - Advanced melanoma, the most deadly form of skin cancer, can be successfully treated in some cases by vaccinating patients with tumor proteins. How these vaccines work and why they are only effective in some patients remains unclear. Pierre Coulie and colleagues now show, in two articles in the January 17 issue of the Journal of Experimental Medicine, that these vaccines work by increasing the number of immune cells called killer T cells that can attack the tumor.
  01/17/2005 AMNews (AMA), Jan. 24 vol. 48 no. 3 - Government
U.S. health spending hit $1.7 trillion in 2003 - Government officials vow to do more this year to rein in expenditures on care.
  01/17/2005 AMNews (AMA), Jan. 24 vol. 48 no. 3 - Professional Issues
Cardiologists pump up efforts to avert shortage - One proposal could mean that internal medicine programs would lose some third-year residents who provide a bulk of patient care.

<<  <  [521]  [522]  [523]  [524]  [525]  [526[527]  [528]  [529]  [530]  >  >>